Document Top

Educational webcast

Click on any video or slide deck title to view or download that resource.

  • Anti-VEGF therapy: innovating NSCLC treatment

    Anti-VEGF therapy: innovating NSCLC treatment

    An overview of Avastin clinical data (Prof Román Pérez-Soler)

    View

  • Avastin in CRC: treat to progression

    Avastin in CRC: treat to progression

    Survival data from trials of Avastin plus chemotherapy in patients with mCRC (Prof Axel Grothey)

    View

  • Inhibiting angiogenesis

    Inhibiting angiogenesis

    Inhibiting angiogenesis: a mechanistic evaluation (Prof Román Pérez‐Soler)

    View

  • Anti-VEGF therapy for NSCLC

    Anti-VEGF therapy for NSCLC

    The importance of anti-VEGF therapy for continued tumour control (Dr Ulrich Gatzemeier)

    View

x

You are now leaving the www.avastin.net website. Links to all external sites are provided as a resource to our visitors. Hoffmann-La Roche Inc. ("Roche") accepts no responsibility for the content of these sites. Roche does not control these sites, and the opinions, claims, or comments expressed on these sites should not be attributed to Roche, except where indicated. We recommend that you consult with your physician or other healthcare provider to obtain more information about any Roche prescription medication.

OK Cancel